World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
13337
World Ranking
3238
National Ranking
1513

Richard Malley publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard Malley sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 170 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard Malley D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Malley sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard Malley is affiliated with Boston Children's Hospital in the United States and has focused primarily on research in Medicine with particular attention to Epidemiology, Infectious Diseases, and Microbiology. Their work also extends into Public Health, Environmental and Occupational Health, and Molecular Biology.

The main topics of Malley's research encompass Pneumonia and Respiratory Infections, Respiratory viral infections, Bacterial Infections and Vaccines, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Pneumocystis jirovecii pneumonia detection and treatment, and Viral gastroenteritis research and epidemiology.

Frequent publication venues where Malley's research appears include Vaccine, Vaccines, bioRxiv (Cold Spring Harbor Laboratory), Clinical Infectious Diseases, and mBio.

Recent papers authored or coauthored by Malley include:

  • Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection, 2022, JAMA Network Open
  • Fostering healthy aging: The interdependency of infections, immunity and frailty, 2021, Ageing Research Reviews
  • Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years, 2022, Vaccine
  • Overview of the Nontyphoidal and Paratyphoidal Salmonella Vaccine Pipeline: Current Status and Future Prospects, 2020, Clinical Infectious Diseases
  • Outcomes of SARS-CoV-2-Positive Youths Tested in Emergency Departments, 2022, JAMA Network Open

Coauthors who frequently collaborate with Malley include Ying-Jie Lu, Amy C. Plint, Anna Funk, Nathan Kuppermann, and Todd A. Florin.

Best Publications

  • Serotype replacement in disease after pneumococcal vaccination

    Daniel M Weinberger;Richard Malley;Marc Lipsitch

  • Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

    Richard Malley;Philipp Henneke;Sarah C. Morse;Michael J. Cieslewicz

  • Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization

    Ying-Jie Lu;Jane Gross;Debby Bogaert;Adam Finn

  • CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization

    Richard Malley;Krzysztof Trzcinski;Amit Srivastava;Claudette M. Thompson

  • Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence

    Daniel M. Weinberger;Krzysztof Trzciński;Ying-Jie Lu;Debby Bogaert

  • Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein

    Richard Malley;John DeVincenzo;Octavio Ramilo;Penelope H. Dennehy

  • TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization

    Kristin L. Moffitt;Todd M. Gierahn;Ying-jie Lu;Paulo Gouveia

  • Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis.

    Lise E. Nigrovic;Richard Malley;Charles G. Macias;John T. Kanegaye

  • Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-Haemophilus influenzae era.

    Lise E. Nigrovic;Nathan Kuppermann;Richard Malley

  • Interference between Streptococcus pneumoniae and Staphylococcus aureus: In Vitro Hydrogen Peroxide-Mediated Killing by Streptococcus pneumoniae

    Gili Regev-Yochay;Krzysztof Trzciński;Claudette M. Thompson;Richard Malley

  • The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease

    Amit Srivastava;Philipp Henneke;Alberto Visintin;Sarah C. Morse

  • Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

    Richard Malley;Marc Lipsitch;Anne Stack;Richard Saladino

  • Antibody-Independent, Interleukin-17A-Mediated, Cross-Serotype Immunity to Pneumococci in Mice Immunized Intranasally with the Cell Wall Polysaccharide

    Richard Malley;Amit Srivastava;Marc Lipsitch;Claudette M. Thompson

  • Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways

    Philipp Henneke;Philipp Henneke;Osamu Takeuchi;Richard Malley;Egil Lien

  • Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease

    Marc Lipsitch;Cynthia G Whitney;Elizabeth Zell;Tarja Kaijalainen

  • Epidemiologic Evidence for Serotype-Specific Acquired Immunity to Pneumococcal Carriage

    Daniel M. Weinberger;Ron Dagan;Noga Givon-Lavi;Gili Regev-Yochay

  • The classical lancefield antigen of group a streptococcus is a virulence determinant with implications for vaccine design

    Nina M. van Sorge;Nina M. van Sorge;Jason N. Cole;Jason N. Cole;Kirsten Kuipers;Anna Henningham

  • Next generation pneumococcal vaccines.

    Kristin L Moffitt;Richard Malley

  • Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.

    Eun Hwa Choi;Fan Zhang;Ying Jie Lu;Richard Malley

  • Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity

    Fan Zhang;Ying-Jie Lu;Richard Malley

  • Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation.

    Deborah C. Molrine;Joseph H. Antin;Eva C. Guinan;Robert J. Soiffer

  • Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development

    Richard Malley;Richard Malley

Frequent Co-Authors

Marc Lipsitch
Marc Lipsitch Harvard University
Krzysztof Trzciński
Krzysztof Trzciński Utrecht University
Adam Finn
Adam Finn University of Bristol
Mark R. Alderson
Mark R. Alderson Program for Appropriate Technology in Health
Ron Dagan
Ron Dagan Ben-Gurion University of the Negev
Douglas T. Golenbock
Douglas T. Golenbock University of Massachusetts Chan Medical School
Victor Nizet
Victor Nizet University of California, San Diego
John P. DeVincenzo
John P. DeVincenzo Middle Tennessee State University
Ethan Rubinstein
Ethan Rubinstein University of Manitoba
Nicholas J. Croucher
Nicholas J. Croucher Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare fields can open diverse career opportunities. One popular option is nursing, which offers various entry points from non-clinical backgrounds. Many universities now offer online nursing programs for non nurses, making it easier to transition into healthcare roles without prior experience.

Accelerated nursing paths, such as easiest absn programs to get into, provide faster routes to becoming a registered nurse (RN). These programs are designed to accommodate career changers and help students meet licensure requirements promptly.

For those starting their nursing journey, lpn schools easy to get into offer practical training programs that require less time and offer foundational knowledge that can complement immunology studies.

Advancing further, Nurse Practitioner degrees are in high demand and easiest online nurse practitioner programs provide flexible learning options for those aiming to specialize in clinical practice with an immunology focus.

Best Scientists Citing Richard Malley

Trending Scientists

Recently Published Articles